MedinCell announces its participation in the Jefferies London Healthcare Conference 2022, 15-17 November in London
November 8, 2022
Previous PostFrance : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments
Next PostMedinCell announces the initiation of Phase 3 study of F14 (mdc-CWM), a therapeutic first-in-class that aims to provide weeks of localized pain relief after Total Knee Replacement
